2026 Lipid Guidelines Beyond Statins: Non- Statin Agents to Manage Dyslipidemias
-
June 12, 2026
June 12, 2026
In a phase 2b trial, the highest dose produced an estimated 12% mean weight reduction vs 1% with placebo, although gastrointestinal adverse events were common.
July 16, 2026
Creatine's ATP-buffering trick isn't just for biceps. In mice, it juices up dendritic cells' energy supply, sharpening T-cell priming and shrinking tumors on daily injections. Human DCs got the memo too, at least in a dish. Early days, but a fun plot twist for gym-bag chemistry.
by Kerri Miller
July 8, 2026
The oral compound increased energy expenditure, reduced fat mass, and improved metabolic measures in male mouse models.
August 27, 2026